Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-  in Cerebrospinal Fluid

(2014) A. Leinenbach et al.   CLINICAL CHEMISTRY

CSF biomarker variability in the Alzheimer's Association quality control program

(2013) Niklas Mattsson et al.   Alzheimers & Dementia

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis

(2013) Sylvain Lehmann et al.   Alzheimers & Dementia

Atomic structure and hierarchical assembly of a cross-  amyloid fibril

(2013) A. W. P. Fitzpatrick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update

(2012) Marta del Campo et al.   Biomarkers in Medicine

Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis

(2012) A. Perret-Liaudet et al.   CLINICAL CHEMISTRY

Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment

(2012) Erik Portelius et al.   CURRENT PHARMACEUTICAL DESIGN

Evaluation of the Performance of Novel Aß Isoforms as Theragnostic Markers in Alzheimer’s Disease: From the Cell to the Patient

(2012) Erik Portelius et al.   Neurodegenerative Diseases

Revision of the criteria for Alzheimer's disease: A symposium

(2011) Steven T. DeKosky et al.   Alzheimers & Dementia

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2011) Hugo Vanderstichele et al.   Alzheimers & Dementia

Analysis of Amyloid-β Peptides in Cerebrospinal Fluid Samples by Capillary Electrophoresis Coupled with LIF Detection

(2011) Romain Verpillot et al.   ANALYTICAL CHEMISTRY

Evaluation of absolute peptide quantitation strategies using selected reaction monitoring

(2011) James Campbell et al.   PROTEOMICS

Neurodegenerative dementia and Parkinsonism

(2010) Audrey Gabelle et al.   Journal of Nutrition Health & Aging

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS

(2010) Valentina Albertini et al.   Proteomics Clinical Applications

A screening UHPLC–MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species

(2010) Lieve Dillen et al.   Bioanalysis

Interest of CSF markers in positive diagnosis of Alzheimer's disease in routine clinical practice

(2009) Audrey Gabelle et al.   Alzheimers & Dementia

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid

(2009) Timo Grimmer et al.   BIOLOGICAL PSYCHIATRY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Clinical proteomics in neurodegenerative disorders

(2008) H. Zetterberg et al.   ACTA NEUROLOGICA SCANDINAVICA

Targeted proteomics in Alzheimer’s disease: focus on amyloid-β

(2008) Erik Portelius et al.   Expert Review of Proteomics